1. Share Prices

  2. Ixico PLC (IXI)

7.38p-0.25 (-3.28%)10 May 2024, 16:10
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Ixico PLC Fundamentals

Company NameIxico PLCLast Updated2024-05-10
IndustryBiotechnologySectorHealthcare
Shares in Issue48.351 mMarket Cap£3.57 m
PE Ratio76.34Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0298Debt Equity Ratio0.0241
Asset Equity Ratio1.1363Cash Equity Ratio0.3526
Quick Ratio4.4473Current Ratio4.91
Price To Book Value0.3225ROCE0

Ixico PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ixico PLC Company Financials

Assets202320222021
Tangible Assets£518,000.00£817,000.00£1.08 m
Intangible Assets£6.15 m£4.59 m£2.71 m
Investments000
Total Fixed Assets£6.70 m£5.40 m£3.79 m
Stocks000
Debtors£1.67 m£3.00 m£3.29 m
Cash & Equivalents£4.03 m£5.77 m£6.68 m
Other Assets000
Total Assets£12.99 m£14.65 m£14.26 m
Liabilities202320222021
Creditors within 1 year£1.28 m£1.74 m£2.15 m
Creditors after 1 year£277,000.00£427,000.00£633,000.00
Other Liabilities000
Total Liabilities£1.56 m£2.16 m£2.78 m
Net assets£11.43 m£12.49 m£11.48 m
Equity202320222021
Called up share capital£484,000.00£482,000.00£482,000.00
Share Premium£92.26 m£92.26 m£92.26 m
Profit / Loss-£1.36 m£885,000.00£1.10 m
Other Equity£11.43 m£12.49 m£11.48 m
Preference & Minorities000
Total Capital Employed£11.43 m£12.49 m£11.48 m
Ratios202320222021
Debt Ratio£0.02£0.03£0.04
Debt-to-Equity£0.02£0.03£0.05
Assets / Equity1.13631.13631.1363
Cash / Equity0.35260.35260.3526
EPS-£0.02£0.02£0.03
Cash Flow202320222021
Cash from operating activities£302,000.00£1.42 m£613,000.00
Cashflow before financing£146,000.00£1.31 m£883,000.00
Increase in Cash-£1.72 m-£929,000.00-£1.27 m
Income202320222021
Turnover£6.67 m£8.64 m£9.19 m
Cost of sales£3.40 m£3.40 m£3.17 m
Gross Profit£3.27 m£5.24 m£6.02 m
Operating Profit-£1.44 m£908,000.00£1.12 m
Pre-Tax profit-£1.36 m£885,000.00£1.10 m

Ixico PLC Company Background

SectorHealthcare
ActivitiesIXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medicalimaging operations and post-marketing surveillance.
Latest Interim Date21 May 2024
Latest Fiscal Year End Date5 Dec 2023

Ixico PLC Directors

AppointedNamePosition
2014-02-28Mr. Alistair Henderson TaylorNon-Executive Director,Chairman
2014-02-28Mr. Roger HicklingExecutive Director,Research and Development Director
2012-05-30Mr. Alexander Dunbar Sandy MorrisonNon-Executive Director
2016-09-16Dr. Andrew John McGlashan Richards CBENon-Executive Director,Chairman
2014-02-28Dr. Peter Robin BlowerNon-Executive Director
2019-12-13Mr. Timothy SharpingtonNon-Executive Director
2007-06-07Dr. Paul Michael Whitney BSc,PhD,MBANon-Executive Director,Chairman
2011-08-09Dr. Richard Peter Dixey, B.A.,M. Sc.,PhDExecutive Director,Chief Executive Officer
2022-04-29Mr. John BradshawNon-Executive Director
2024-01-25Mr. Charles Alexander Evan SpicerNon-Executive Director,Chairman
2011-08-09Mr. Piers John MorganExecutive Director,Chief Financial Officer
2011-08-09Dr. Daryl David Rees, B.Sc. ,M.Sc.,PhDExecutive Director,Chief Executive Officer
2018-01-22Professor Derek Lionel Glendon HillExecutive Director
2016-01-08Ms. Maina BhamanNon-Executive Director
2021-12-17Ms. Susan Day LowtherExecutive Director,Chief Financial Officer and Company Secretary
2023-12-04Mr. Mark Robert WarneNon-Executive Director,Chairman
2023-12-04Mr. Giulio CerroniExecutive Director,Chief Executive Officer
2023-12-04Mr. Grant Robert Nash Executive Director,Chief Financial Officer and Company Secretary

Ixico PLC Contact Details

Company NameIXICO PLC
Address15 Long Lane, 4th Floor, Griffin Court, London, EC1A 9PN
Telephone+44 2037637499
Websitehttps://www.ixico.com

Ixico PLC Advisors

StockbrokerShore Capital Stockbrokers Ltd
Phone+44 2074084050
Fax+44 2074084091
Nominated AdviserShore Capital & Corporate Ltd
Phone+44 2074084050
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
AuditorGrant Thornton UK LLP
Phone+44 1223225600
Fax+44 1223225619
SolicitorBristows
Phone+44 2074008000
Fax+44 2074008050
RegistrarEquiniti Ltd.
Phone+44 1214157082
Remuneration ConsultantNew Bridge Street
Phone+44 2070869341
Fax+44 2070869341
Financial AdviserRothschild
Phone+44 2072805000
BankHBOS PLC

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
09 May 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Future PLC830.007.10
Marshalls PLC310.005.98
W.A.G Payment Solutions PLC71.804.06
Tbc Bank Group PLC3,000.003.63
Wizz Air Holdings PLC2,216.003.55
Kainos Group PLC1,030.003.41

Fallers

CompanyPrice% Chg
Rightmove PLC541.20-5.52
Auction Technology Group PLC483.00-3.59
Bbgi Global Infrastructure S.A.137.40-3.38
Playtech PLC481.00-2.63
Rolls-Royce Holdings PLC423.60-2.37
Hunting PLC371.50-2.11